Table 4 |
|||
|
Vascular outcome measurements |
|||
|
Placebo (n = 79) |
Vitamins (n = 83) |
p |
|
|
|
|||
|
Vascular Structure |
|||
|
Carotid intima-medial thickness (mm) |
0.83 ± 0.18 |
0.84 ± 0.17 |
0.74 |
|
Carotid lumen diameter (mm) |
6.35 ± 0.72 |
6.49 ± 0.94 |
0.31 |
|
Brachial artery diameter (mm) |
3.66 ± 0.67 |
3.84 ± 0.82 |
0.12 |
|
Vascular Function |
|||
|
Flow-mediated dilation (%) |
3.0 (0.6 – 6.6) |
4.0 (0.9 – 7.2) |
0.48 |
|
GTN-mediated dilation (%) |
20.2 ± 7.4 |
20.2 ± 8.1 |
0.98 |
|
|
|||
|
GTN indicates glyeryl trinitrate. Values are mean ± standard deviation or median (inter-quartile range) P-values are from a two-sample t-test or a two-sample rank test (Mann-Whitney) |
|||
|
Potter et al. BMC Cardiovascular Disorders 2008 8:24 doi:10.1186/1471-2261-8-24 |
|||